2012-10-10 21:43:47 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Nabi Biopharmaceuticals - Product Pipeline Review - 2012" provides data on the Nabi Biopharmaceuticals's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Nabi Biopharmaceuticals's corporate website, SEC filings, investor presentations and featured press releases, both from Nabi Biopharmaceuticals and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Nabi Biopharmaceuticals - Brief Nabi Biopharmaceuticals overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Nabi Biopharmaceuticals human

therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Nabi Biopharmaceuticals with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Nabi Biopharmaceuticals's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468679_nabi_biopharmaceuticals_product_pipel ..


Reasons to buy

* Evaluate Nabi Biopharmaceuticals's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Nabi Biopharmaceuticals in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Nabi Biopharmaceuticals's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Nabi Biopharmaceuticals.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Nabi Biopharmaceuticals and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Nabi Biopharmaceuticals Snapshot
Nabi Biopharmaceuticals Overview
Key Information
Key Facts
Nabi Biopharmaceuticals - Research and Development Overview
Key Therapeutic Areas
Nabi Biopharmaceuticals - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Nabi Biopharmaceuticals - Pipeline Products Glance
Nabi Biopharmaceuticals - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Nabi Biopharmaceuticals - Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
Nabi Biopharmaceuticals - Drug Profiles
EnteroVAX
Product Description
Mechanism of Action
R&D Progress
NicVAX
Product Description
Mechanism of Action
R&D Progress
RENs
Product Description
Mechanism of Action
R&D Progress
Nabi Biopharmaceuticals - Pipeline Analysis
Nabi Biopharmaceuticals - Pipeline Products by Therapeutic Class
Nabi Biopharmaceuticals - Pipeline Products by Route of Administration
Nabi Biopharmaceuticals - Pipeline Products By Mechanism of Action
Nabi Biopharmaceuticals - Recent Pipeline Updates
Nabi Biopharmaceuticals - Dormant Projects
Nabi Biopharmaceuticals - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
StaphVAX
Nabi Biopharmaceuticals - Company Statement
Nabi Biopharmaceuticals - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Nabi Biopharmaceuticals, Recent Developments
Nabi Biopharmaceuticals- Press Release
Sep 29, 2009: Nabi Biopharmaceuticals Receives Grant Supporting Further NicVAX Development
Jun 03, 2009: Nabi Biopharmaceuticals Receives Scientific Advice On NicVAX From The European Medicines Agency
Financial Deals Landscape
Nabi Biopharmaceuticals, Deals Summary
Nabi Biopharmaceuticals, Pharmaceuticals & Healthcare, Deal Details
Partnerships
Nabi BioPharma Enters Into Research Agreement With USU And The Henry M. Jackson Foundation
Nabi BioPharma Enters Into Collaboration With National Institute Of Allergy And Infectious Diseases
Nabi BioPharma Enters Into Co-Development Agreement With Kedrion
Merger
Biota To Merge With Nabi Biopharma
Licensing Agreements
Nabi BioPharma Enters Into License Agreement With GlaxoSmithKline
Nabi BioPharma Enters Into Agreement With ProMetic Life Sciences
Asset Transactions
GlaxoSmithKline Acquires PentaStaph And Related Assets From Nabi BioPharma
Biotest Acquires Biologics Business Unit From Nabi BioPharma
Bioniche Teoranta Acquires Aloprim From Nabi BioPharma
Fresenius Medical Care Acquires Rights Of PhosLo From Nabi BioPharma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Nabi Biopharmaceuticals, Key Information
Nabi Biopharmaceuticals, Key Facts
Nabi Biopharmaceuticals - Pipeline by Indication, 2012
Nabi Biopharmaceuticals - Pipeline by Stage of Development, 2012
Nabi Biopharmaceuticals - Monotherapy Products in Pipeline, 2012
Nabi Biopharmaceuticals - Phase III, 2012
Nabi Biopharmaceuticals - Discovery, 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468679&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.